Not applicableStudy completedNCT00873210What this trial is testingStudy In Patients With Kidney Cancer Treated With SutentWho this might be right forAdvanced or Metastatic Renal Cell CarcinomaRenal Cancer Pfizer 121
Early research (Phase 1)Looking for participantsNCT07623369What this trial is testingA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forSolid TumorNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Huahui Health 299
Testing effectiveness (Phase 2)Looking for participantsNCT07469683What this trial is testingAn Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell CarcinomaNeoplasmsMalignant Neoplasms+1 more Yonsei University 78
Testing effectiveness (Phase 2)Study completedNCT00277017What this trial is testingCombination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell CarcinomaWho this might be right forKidneyCancer New Mexico Cancer Research Alliance 15
Early research (Phase 1)Ended earlyNCT03260504What this trial is testingAldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney CancerWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer+1 more University of Washington 6
Testing effectiveness (Phase 2)Study completedNCT00182702What this trial is testingIxabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more National Cancer Institute (NCI) 37
Early research (Phase 1)Ended earlyNCT02650635What this trial is testingTLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsWho this might be right forColorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Breast Carcinoma+14 more Mayo Clinic 4
Not applicableEnded earlyNCT03692338What this trial is testingINTERVAL: Ipilimumab and Nivolumab Combination Therapy: A Study of a Supervised or Semi-Supervised Exercise InteRVention or Usual Care With Functional Capacity and Quality of Life Evaluations in Subjects With Advanced or Metastatic RenAL Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Duke University 2
Not applicableActive Not RecruitingNCT04106349What this trial is testingObservational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)Who this might be right forAdvanced or Metastatic Renal Cell Carcinoma Ipsen 150
Testing effectiveness (Phase 2)Looking for participantsNCT04977453What this trial is testingGI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorCervical Cancer+3 more GI Innovation, Inc. 317
Testing effectiveness (Phase 2)Looking for participantsNCT07188896What this trial is testingTrial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)Who this might be right forAdvanced Renal Cell Carcinoma (aRCC)Metastatic Renal Cell Carcinoma ( mRCC)Clear Cell Renal Cell Carcinoma (ccRCC) Brian Rini 120
Testing effectiveness (Phase 2)UnknownNCT02689167What this trial is testingStudy to Assess Various Sunitinib Schedules in Renal Cell CarcinomaWho this might be right forKidney NeoplasmsMetastatic Renal Cell Cancer Centre Hospitalier Universitaire de Besancon 226
Large-scale testing (Phase 3)Looking for participantsNCT07197580What this trial is testingPhase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCCWho this might be right forccRCCRenal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)+3 more Telix Pharmaceuticals (Innovations) Pty Limited 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07470840What this trial is testingSBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell CarcinomaWho this might be right forLocally Advanced or Metastatic Renal Cell Carcinoma Fujian Cancer Hospital 27
Early research (Phase 1)Active Not RecruitingNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134What this trial is testingStudy of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerWho this might be right forCancerTumor, SolidAdvanced Solid Tumor+19 more Salubris Biotherapeutics Inc 263
Testing effectiveness (Phase 2)Study completedNCT05597839What this trial is testingStudy of DF9001 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Dragonfly Therapeutics 24
Testing effectiveness (Phase 2)Study completedNCT00331409What this trial is testingEverolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forKidney Cancer OHSU Knight Cancer Institute 23
Testing effectiveness (Phase 2)Looking for participantsNCT06265025What this trial is testingGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsWho this might be right forHead and Neck CancerMalignant MelanomaColorectal Cancer+3 more GeneMedicine Co., Ltd. 125
Testing effectiveness (Phase 2)Study completedNCT03428217What this trial is testingCANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell CarcinomaWho this might be right forAdvanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma Calithera Biosciences, Inc 444